97 South Street, Hopkinton, MA 01748; a subsidiary of Ligand Pharmaceuticals; founded in 1979 as a joint venture of Boston Univ. and several faculty members, with minority interest held by Nycomed AS, which acquired by the company in Aug. 1987; Ligand acquired Seragen in mid-1998; Ligand also paid $50 million to Boston Univ. to acquire Marathon Biopharmaceuticals LLC (Hopkinton, MA), subsequently renamed to SmallPharma LLC, which had been Seragen’s manufacturing and clinical operations center; SmallPharma now concentrates on third party contract manufacture and manufacture of ONTAK for Ligand.
